Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Change in Receivables (2016 - 2026)

Integra Lifesciences Holdings' Change in Receivables history spans 17 years, with the latest figure at $16.5 million for Q4 2025.

  • On a quarterly basis, Change in Receivables fell 47.71% to $16.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $485000.0, a 106.56% increase, with the full-year FY2025 number at $485000.0, up 106.56% from a year prior.
  • Change in Receivables hit $16.5 million in Q4 2025 for Integra Lifesciences Holdings, up from -$22.5 million in the prior quarter.
  • Over the last five years, Change in Receivables for IART hit a ceiling of $31.5 million in Q4 2024 and a floor of -$28.8 million in Q3 2024.
  • Historically, Change in Receivables has averaged $756700.0 across 5 years, with a median of $4.2 million in 2022.
  • The widest YoY moves for Change in Receivables: up 6784.68% in 2024, down 12734.82% in 2024.
  • Tracing IART's Change in Receivables over 5 years: stood at $10.2 million in 2021, then decreased by 1.35% to $10.0 million in 2022, then tumbled by 95.45% to $457000.0 in 2023, then surged by 6784.68% to $31.5 million in 2024, then plummeted by 47.71% to $16.5 million in 2025.
  • Business Quant data shows Change in Receivables for IART at $16.5 million in Q4 2025, -$22.5 million in Q3 2025, and $28.0 million in Q2 2025.